Aphria Inc. (TSX: APH or US OTC: APHQF) today announced that it has finalized the previously announced supply agreement with the Société des alcools du Québec ("SAQ"). The three-year agreement for up to 12,000 kg annually guarantees a supply of high-quality, safe and clean cannabis products for sale in the Quebec adult-use market, through the Société québécoise du cannabis' (SQDC) retail outlets and e-commerce platform.
"We are very pleased to finalize this agreement with the SAQ and look forward to supplying the Quebec adult-use market with a variety of high-quality, safe and pure cannabis products," said Vic Neufeld, Chief Executive Officer of Aphria. "Our product and brand portfolio has been specifically developed to meet the needs of very distinct market segments, and we look forward to offer adult-use consumers in Quebec a unique choice."
With fully-funded production capacity of approximately 230,000 kg online by early 2019, Aphria is extremely well positioned to supply the anticipated adult-use demand across Canada, including in the country's second-largest market. Under the terms of the agreement, Aphria will supply the future SQDC with a variety of branded cannabis products from the Company's adult-use brand portfolio, which will include cannabis oils and other derivative products and several strains of high-quality grown dried cannabis flower.
The agreement is conditional on the adoption, by the federal and provincial governments, of the necessary regulatory framework.
Aphria Inc., one of Canada's lowest cost producers, produces, supplies and sells medical cannabis. Located in Leamington, Ontario, the greenhouse capital of Canada, Aphria is truly powered by sunlight allowing for the most natural growing conditions available. Aphria is committed to providing pharma-grade medical cannabis, superior patient care while balancing patient economics and returns to shareholders.
For more information, visit www.aphria.ca
Read original release